Pharmaceuticals - Community Register


List of referrals for human medicinal products


Product name: Roferon-A
Also marketed in the EU under the name(s): Roceron-A, Roféron-A
Active substance: interferon alfa-2a
Indication: Treatment of leukemia, lymphoma, chronic hepatitis B and C, advanced renal cell carcinoma, patients with AJCC stage II malignant melanoma
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/06/1999 Referral EMEA/H/A-36/260 (1999)1628 of 16/06/1999